Key facts
- It has raised $24.4M; the latest was Later Stage VC ($24.4M) in Sep 2025.
- Notable investors include China State-owned Enterprise Mixed Ownership Reform Fund, TTCO Trust, Chengdu Wuhou Technology Innovation Industry Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ganlu Traditional Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for Ganlu Traditional Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ganlu Traditional Medicine
Developer of traditional Tibetan medicine designed for healing and health preservation. The company offers a range of patented and nationally recognized medicinal products, including heritage formulations and unique processing techniques, enabling healthcare practitioners and patients access to effective, culturally rooted treatments that integrate traditional knowledge with modern quality standards.
- Sector
- Healthcare
- HQ
- Lhasa, China
- Founded
- 1998
- Employees
- 419
- Website
- glzy.cn/
- Ownership
- Privately Held (backing)
Ganlu Traditional Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ganlu Traditional Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ganlu Traditional Medicine in its N-PORT filings yet. We sweep new filings monthly.